ES2045768T3 - Composiciones topicas que contienen defibrotida. - Google Patents

Composiciones topicas que contienen defibrotida.

Info

Publication number
ES2045768T3
ES2045768T3 ES90202172T ES90202172T ES2045768T3 ES 2045768 T3 ES2045768 T3 ES 2045768T3 ES 90202172 T ES90202172 T ES 90202172T ES 90202172 T ES90202172 T ES 90202172T ES 2045768 T3 ES2045768 T3 ES 2045768T3
Authority
ES
Spain
Prior art keywords
compositions containing
topic compositions
defibrotide
containing defibrotide
topic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90202172T
Other languages
English (en)
Inventor
Marisa Mantovani
Giuseppe Prino
Roberto Porta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Crinos Industria Farmacobiologica SpA
Original Assignee
Crinos Industria Farmacobiologica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmacobiologica SpA filed Critical Crinos Industria Farmacobiologica SpA
Application granted granted Critical
Publication of ES2045768T3 publication Critical patent/ES2045768T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/755—Polymers containing halogen
    • A61K31/76—Polymers containing halogen of vinyl chloride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

COMPOSICION FARMACEUTICA PARA USO ACTUAL COTENIENDO DEFIFROIDES HABIENDO ENCONTRADO EFECTIVIDAD EN LA PATOLOGIA LOCAL CARACTERIZADA POR UNA REDUCIDA RESISTENCIA DE EL VASO CAPILAR DE LA SANGRE.
ES90202172T 1989-09-07 1990-08-10 Composiciones topicas que contienen defibrotida. Expired - Lifetime ES2045768T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8921651A IT1231509B (it) 1989-09-07 1989-09-07 Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.

Publications (1)

Publication Number Publication Date
ES2045768T3 true ES2045768T3 (es) 1994-01-16

Family

ID=11184862

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90202172T Expired - Lifetime ES2045768T3 (es) 1989-09-07 1990-08-10 Composiciones topicas que contienen defibrotida.

Country Status (12)

Country Link
US (1) US5116617A (es)
EP (1) EP0416678B1 (es)
JP (1) JPH0399019A (es)
KR (1) KR910005876A (es)
AT (1) ATE97001T1 (es)
AU (1) AU623028B2 (es)
CA (1) CA2021874A1 (es)
DE (1) DE69004532T2 (es)
DK (1) DK0416678T3 (es)
ES (1) ES2045768T3 (es)
IT (1) IT1231509B (es)
PT (1) PT95212B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
EP1147777A1 (en) * 2000-04-18 2001-10-24 Crinos Industria Farmacobiologica S.p.A. Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
US7029657B2 (en) * 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
EP1872787A1 (en) * 2006-06-27 2008-01-02 Gentium S.p.A. Use of defibrotide for the inhibition of heparanase
EP2103689A1 (en) 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
US8980862B2 (en) 2010-11-12 2015-03-17 Gentium S.P.A. Defibrotide for use in prophylaxis and/or treatment of Graft versus Host Disease (GVHD)
BR112014031934B1 (pt) 2012-06-22 2021-05-04 Gentium S.R.L. método com base em euglobulina para determinar a atividade biológica de defibrotide
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CA3071544A1 (en) 2017-08-03 2019-02-07 Jazz Pharmaceuticals Ireland Limited Formulations comprising a nucleic acid in a high concentration
KR20210008478A (ko) 2018-04-12 2021-01-22 재즈 파마슈티칼즈, 인코포레이티드 면역고갈과 관련된 사이토카인 방출 증후군 및 신경독성의 예방 및 치료를 위한 데피브로타이드
WO2020118165A1 (en) 2018-12-07 2020-06-11 Jazz Pharmaceuticals Ireland Limited Subcutaneous delivery of high concentration formulations
EP4110287A1 (en) 2020-02-28 2023-01-04 Jazz Pharmaceuticals Ireland Limited Delivery of low viscosity formulations
WO2021212055A1 (en) 2020-04-17 2021-10-21 Jazz Pharmaceuticals Ireland Limited Defibrotide treatment for the prevention of organ rejection and injury
TW202308659A (zh) 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
IT1170214B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per la cura delle arteriopatie periferiche
IT1170215B (it) * 1983-09-12 1987-06-03 Crinos Industria Farmaco Composizione farmaceutica per il trattamento di stati di insufficienza renale acuta
IT1206341B (it) * 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.

Also Published As

Publication number Publication date
DK0416678T3 (da) 1993-12-20
IT8921651A0 (it) 1989-09-07
EP0416678A1 (en) 1991-03-13
KR910005876A (ko) 1991-04-27
AU623028B2 (en) 1992-04-30
PT95212A (pt) 1991-05-22
CA2021874A1 (en) 1991-03-08
AU5917390A (en) 1991-03-14
US5116617A (en) 1992-05-26
PT95212B (pt) 1997-06-30
EP0416678B1 (en) 1993-11-10
DE69004532T2 (de) 1994-02-24
IT1231509B (it) 1991-12-07
DE69004532D1 (de) 1993-12-16
JPH0399019A (ja) 1991-04-24
ATE97001T1 (de) 1993-11-15

Similar Documents

Publication Publication Date Title
ES2045768T3 (es) Composiciones topicas que contienen defibrotida.
ES2173978T3 (es) Utilizacion de un alcohol graso insaturado.
ES2135613T3 (es) Articulo dental que contiene una pasta curable por luz.
DE69019022D1 (de) Ölige Pasten-Zusammensetzung.
ES507527A0 (es) Perfeccionamientos en mesas de operaciones para la cirugia de manos.
BR8802948A (pt) Composicao nao aquosa liquida para limpeza e metodo de uso,e embalagem da mesma
DE69014519D1 (de) Ionomer-Zusammensetzung.
DE69007650D1 (de) Ionomer-Zusammensetzung.
DE69415223D1 (de) Feste, transparente Seifenzusammensetzung auf Basis von Fettsäuresalzen, enthaltend Isoprenglykol
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
ES2018478B3 (es) Un sistema para preparar una composicion desensibilizante dental.
FI904444A0 (fi) Aktiva limkompositioner.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
ES2165723T3 (es) Composiciones farmaceuticas conteniendo mupirocina.
IT8367881A0 (it) Derivato proteinico che ha innestati dei residui assorbitori di ultravioletti procedimento per la sua preparazione e composizioni che lo contengono
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
ES2133285T3 (es) Polipeptidos hidrosolubles que tienen una alta afinidad para los interferones alfa y beta.
DE3863468D1 (de) Dispergiermittel fuer oelige zusammensetzungen.
BR8900382A (pt) Composicao cremosa para desengorduramento,contendo abrasivo
DE69025322D1 (de) Flüssige prostaglandinzusammensetzung
IT8919172A0 (it) Composizioni contenenti bismuto idonee per uso terapeutico.
BR9806193A (pt) Composição bi-aromáticos ligados por um radical heteroetinileno e composições farmacêuticas e cosméticas que os contêm
BR9001553A (pt) Composicao para uso na formulacao de detergentes
IT8521484A0 (it) Composizione non tossica da usarsi nel montaggio di vetrini per microscopio.
DE3864865D1 (de) Duftzusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 416678

Country of ref document: ES